TP53 and neoplasm: In order to further investigate whether the MortaparibPlus-mediated activation of wild-type p53 function in MCF-7 cells could effectively initiate p53-mediated tumor suppression cell fates, we examined apoptosis initiation and cell cycle progression in control and treated cells by flow cytometry.